First Affiliated Hospital Of Fujian Medical University

This study tests a low-dose radioactive drug (177Lu-P17-088) that targets a protein called PSMA on prostate cancer cells. It is for people with metastatic castration-resistant prostate cancer that has stopped responding to hormone therapy. The goal is to see if the treatment can …

This study tests a new radioactive drug called 225Ac-LNC1011 in men with metastatic castration-resistant prostate cancer that has spread and stopped responding to hormone therapy. The drug targets a protein (PSMA) on cancer cells to deliver radiation directly. Nine participants w…

This study looks at whether adding rifampin to standard antibiotics can better clear staphylococcal infections in artificial joints after surgery. About 428 adults with infected joint replacements will receive either standard antibiotics or standard antibiotics plus rifampin for …

This study looks at whether taking a specific gut bacterium (Bacteroides fragilis) along with branched-chain amino acids can help clear the hepatitis B virus in people with chronic infection. About 40 participants will receive this combo as an add-on to their usual antiviral trea…

This study compares three imaging methods—FAPI PET/MRI, FDG PET/MRI, and MRI—to see which best detects muscle-invasive bladder cancer and tracks how well pre-surgery treatment works. Researchers will enroll 80 participants with suspected or confirmed bladder cancer. The goal is t…

This study tests whether using a special scan (PSMA PET/MRI) to guide prostate biopsies can find cancers that standard methods miss. It includes 230 men with elevated PSA, at least one prior negative biopsy, and low-risk MRI results. The goal is to improve early detection of clin…

This study tests two new imaging agents (68Ga-G21 and 68Ga-G23) that target a protein found on most prostate cancer cells. The goal is to see if these PET scans can find cancers that standard PSMA scans might miss, helping doctors better stage the disease and guide treatment. Six…

This study aims to see if a special PET scan (68Ga-PSMA-11) is better than standard MRI at finding prostate tumors in people who have just been diagnosed and haven't started treatment. About 100 participants will receive both scans before surgery, and the results will be checked …

This study is testing a new radioactive tracer called 68Ga-P16-093 for PET scans to see how well it finds prostate cancer tumors compared to standard MRI scans. About 50 people with newly diagnosed, untreated prostate cancer will receive both scans before their prostate removal s…

This study tests a simple talking therapy for heart surgery patients while they are still in the ICU. The therapy uses a visitor book with photos and family messages to help patients process stressful memories. Researchers hope this can prevent posttraumatic stress disorder (PTSD…

This early-stage trial tests whether low-intensity focused ultrasound (LIFU) can safely improve motor symptoms in 24 adults with Huntington's disease. Participants receive ultrasound pulses to a brain region involved in movement control. The study focuses on safety and finding th…

This study looks at using different amounts of steroids injected into the knee during total knee replacement surgery to control pain. Researchers want to find the safest and most effective dose to help patients recover faster and feel better. The trial involves 120 adults having …

This study is creating a large database of 8,000 adults with heart, kidney, or metabolic diseases to track their health over up to 5 years. Researchers will collect medical records, imaging, and lab data to understand how these conditions interact and affect long-term outcomes. T…

This study looks at how well three AI models—ChatGPT, Gemini, and Deepseek—can diagnose and suggest treatments for urology diseases. Researchers will use 800 past patient records from four hospitals to check the AI's accuracy and usefulness. The goal is to understand if AI can he…

This study will follow 20,000 adults in rural China for three years to understand how chronic diseases like high blood pressure, diabetes, and frailty develop. Participants will provide health data and samples to build a comprehensive database. The goal is to create better diseas…